Bank Pictet & Cie Europe AG lessened its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 33.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,867 shares of the company's stock after selling 9,811 shares during the period. Bank Pictet & Cie Europe AG's holdings in Procter & Gamble were worth $2,886,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in PG. BlackRock Inc. acquired a new stake in shares of Procter & Gamble in the second quarter valued at approximately $27,862,105,000. State Street Corp lifted its position in Procter & Gamble by 1.0% during the second quarter. State Street Corp now owns 102,216,308 shares of the company's stock worth $14,988,999,000 after purchasing an additional 965,461 shares during the period. Bank of America Corp DE acquired a new stake in Procter & Gamble during the second quarter worth about $3,850,628,000. Bank of New York Mellon Corp acquired a new stake in Procter & Gamble during the second quarter worth about $2,281,505,000. Finally, Dimensional Fund Advisors LP grew its stake in Procter & Gamble by 2.6% during the first quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company's stock worth $1,704,182,000 after buying an additional 300,280 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Wall Street Analyst Weigh In
PG has been the topic of several recent analyst reports. Evercore raised shares of Procter & Gamble from an "in-line" rating to an "outperform" rating and set a $166.00 target price on the stock in a report on Tuesday, October 6th. Sanford C. Bernstein reaffirmed a "market perform" rating and set a $149.00 price target on shares of Procter & Gamble in a report on Monday, August 24th. Jefferies Financial Group increased their price target on shares of Procter & Gamble from $177.00 to $179.00 and gave the stock a "buy" rating in a research report on Friday, June 26th. JPMorgan Chase & Co. decreased their price objective on shares of Procter & Gamble from $164.00 to $162.00 and set an "overweight" rating on the stock in a research note on Thursday, July 16th. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $166.00 price objective on shares of Procter & Gamble in a research note on Tuesday. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and a consensus target price of $162.20.
Check Out Our Latest Analysis on Procter & Gamble
Key Stories Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Royal Bank of Canada reaffirmed its Outperform rating and set a $166 price target, implying additional upside from current levels. RBC rating report
- Positive Sentiment: P&G marked its 70th consecutive annual dividend increase, reinforcing its appeal to income-focused investors and supporting the stock’s defensive profile. Dividend growth article
- Positive Sentiment: The company’s innovation program—including brand launches, artificial-intelligence capabilities, and productivity initiatives—could improve market share and revive organic sales growth over time. Innovation strategy article
- Positive Sentiment: A new, science-focused Head & Shoulders Scalp Care Collection represents an effort to create more targeted products and strengthen the brand’s positioning. Head & Shoulders product article
- Neutral Sentiment: P&G is scheduled to report fiscal first-quarter 2027 results before the market opens on October 22. Analysts are watching sales volume, pricing, margins, and management’s outlook for signs of improving demand. P&G earnings preview
- Negative Sentiment: The earnings preview highlights a key risk: recovering volumes may be offset by pricing pressure, potentially limiting revenue and profit growth. Earnings preview on volume and pricing
- Negative Sentiment: P&G’s dividend yield is being compared unfavorably with Nike’s roughly 4.4% yield, which may reduce PG’s relative appeal to investors prioritizing current income, although Nike carries greater business and share-price risk. Nike and P&G dividend comparison
Procter & Gamble Price Performance
Procter & Gamble stock opened at $159.34 on Wednesday. The stock has a 50-day moving average price of $147.39 and a two-hundred day moving average price of $146.73. The company has a market capitalization of $370.09 billion, a PE ratio of 22.89, a P/E/G ratio of 3.92 and a beta of 0.39. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating analysts' consensus estimates of $1.41 by $0.02. The company had revenue of $21.20 billion for the quarter, compared to analyst estimates of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The company's quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Analysts expect that Procter & Gamble Company will post 6.98 EPS for the current year.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be issued a $1.0885 dividend. The ex-dividend date is Friday, October 23rd. This represents a $4.35 annualized dividend and a yield of 2.7%. Procter & Gamble's dividend payout ratio is presently 65.71%.
Insiders Place Their Bets
In other news, CEO Paul Gama sold 2,225 shares of the company's stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $323,381.50. Following the transaction, the chief executive officer directly owned 51,124 shares of the company's stock, valued at $7,430,362.16. This represents a 4.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Susan Whaley sold 2,369 shares of the stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $344,310.46. Following the completion of the transaction, the insider owned 30,730 shares in the company, valued at approximately $4,466,298.20. This represents a 7.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 15,135 shares of company stock valued at $2,189,970. 0.23% of the stock is currently owned by corporate insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.